AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
Interleukin-8 receptor (CXCR2) antagonists
Authors: Sarau, HM Widdowson, KL Palovich, MR White, JR Underwood, DC Griswold, DE
Citation: Hm. Sarau et al., Interleukin-8 receptor (CXCR2) antagonists, PROG R RES, 31, 2001, pp. 293-296
Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1
Authors: Dhanak, D Christmann, LT Darcy, MG Jurewicz, AJ Keenan, RM Lee, J Sarau, HM Widdowson, KL White, JR
Citation: D. Dhanak et al., Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1, BIOORG MED, 11(11), 2001, pp. 1441-1444
Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2
Authors: Dhanak, D Christmann, LT Darcy, MG Keenan, RM Knight, SD Lee, J Ridgers, LH Sarau, HM Shah, DH White, JR Zhang, LL
Citation: D. Dhanak et al., Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2, BIOORG MED, 11(11), 2001, pp. 1445-1450
Cloning, expression, and pharmacological characterization of a novel humanhistamine receptor
Authors: Zhu, Y Michalovich, D Wu, HL Tan, KB Dytko, GM Mannan, IJ Boyce, R Alston, J Tierney, LA Li, XT Herrity, NC Vawter, L Sarau, HM Ames, RS Davenport, BM Hieble, JP Wilson, S Bergsma, DJ Fitzgerald, LR
Citation: Y. Zhu et al., Cloning, expression, and pharmacological characterization of a novel humanhistamine receptor, MOLEC PHARM, 59(3), 2001, pp. 434-441
EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes
Authors: Robert, P Tsui, P Laville, MP Livi, GP Sarau, HM Bril, A Berrebi-Bertrand, I
Citation: P. Robert et al., EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes, J MOL CEL C, 33(9), 2001, pp. 1589-1606
Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity andselectivity in quinoline tachykinin receptor antagonists
Authors: Blaney, FE Raveglia, LF Artico, M Cavagnera, S Dartois, C Farina, C Grugni, M Gagliardi, S Luttmann, MA Martinelli, M Nadler, GMMG Parini, C Petrillo, P Sarau, HM Scheideler, MA Hay, DWP Giardina, GAM
Citation: Fe. Blaney et al., Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity andselectivity in quinoline tachykinin receptor antagonists, J MED CHEM, 44(11), 2001, pp. 1675-1689
Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models
Authors: Ames, RS Lee, D Foley, JJ Jurewicz, AJ Tornetta, MA Bautsch, W Settmacher, B Klos, A Erhard, KF Cousins, RD Sulpizio, AC Hieble, JP McCafferty, G Ward, KW Adams, JL Bondinell, WE Underwood, DC Osborn, RR Badger, AM Sarau, HM
Citation: Rs. Ames et al., Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models, J IMMUNOL, 166(10), 2001, pp. 6341-6348
AXOR12, a novel human G protein-coupled receptor, activated by the peptideKiSS-1
Authors: Muir, AI Chamberlain, L Elshourbagy, NA Michalovich, D Moore, DJ Calamari, A Szekeres, PG Sarau, HM Chambers, JK Murdock, P Steplewski, K Shabon, U Miller, JE Middleton, SE Darker, JG Larminie, CGC Wilson, S Bergsma, DJ Emson, P Faull, R Philpott, KL Harrison, DC
Citation: Ai. Muir et al., AXOR12, a novel human G protein-coupled receptor, activated by the peptideKiSS-1, J BIOL CHEM, 276(31), 2001, pp. 28969-28975
Molecular and pharmacological characterization of the murine tachykinin NK3 receptor
Authors: Sarau, HM Feild, JA Ames, RS Foley, JJ Nuthulaganti, P Schmidt, DB Buckley, PT Elshourbagy, NA Brawner, ME Luttmann, MA Giardina, GAM Hay, DWP
Citation: Hm. Sarau et al., Molecular and pharmacological characterization of the murine tachykinin NK3 receptor, EUR J PHARM, 413(2-3), 2001, pp. 143-150
Calmodulin-binding peptide PEP-19 modulates activation of calmodulin kinase II in situ
Authors: Johanson, RA Sarau, HM Foley, JJ Slemmon, JR
Citation: Ra. Johanson et al., Calmodulin-binding peptide PEP-19 modulates activation of calmodulin kinase II in situ, J NEUROSC, 20(8), 2000, pp. 2860-2866
Evidence that the proposed novel human "neurokinin-4" receptor is pharmacologically similar to the human neurokinin-3 receptor but is not of human origin
Authors: Sarau, HM Mooney, JL Schmidt, DB Foley, JJ Buckley, PT Giardina, GAM Wang, DY Lee, JA Hay, DWP
Citation: Hm. Sarau et al., Evidence that the proposed novel human "neurokinin-4" receptor is pharmacologically similar to the human neurokinin-3 receptor but is not of human origin, MOLEC PHARM, 58(3), 2000, pp. 552-559
Identification and molecular characterization of rat CXCR3: Receptor expression and interferon-inducible protein-10 binding are increased in focal stroke
Authors: Wang, XK Li, X Schmidt, DB Foley, JJ Barone, FC Ames, RS Sarau, HM
Citation: Xk. Wang et al., Identification and molecular characterization of rat CXCR3: Receptor expression and interferon-inducible protein-10 binding are increased in focal stroke, MOLEC PHARM, 57(6), 2000, pp. 1190-1198
Nonpeptide tachykinin receptor antagonists. II. Ppharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potentand selective NK-3 receptor antagonist
Authors: Sarau, HM Griswold, DE Bush, B Potts, W Sandhu, P Lundberg, D Foley, JJ Schmidt, DB Webb, EF Martin, LD Legos, JJ Whitmore, RG Barone, FC Medhurst, AD Luttmann, MA Giardina, GAM Hay, DWP
Citation: Hm. Sarau et al., Nonpeptide tachykinin receptor antagonists. II. Ppharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potentand selective NK-3 receptor antagonist, J PHARM EXP, 295(1), 2000, pp. 373-381
Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration
Authors: White, JR Lee, JM Dede, K Imburgia, CS Jurewicz, AJ Chan, G Fornwald, JA Dhanak, D Christmann, LT Darcy, MG Widdowson, KL Foley, JJ Schmidt, DB Sarau, HM
Citation: Jr. White et al., Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration, J BIOL CHEM, 275(47), 2000, pp. 36626-36631
Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor
Authors: Elshourbagy, NA Ames, RS Fitzgerald, LR Foley, JJ Chambers, JK Szekeres, PG Evans, NA Schmidt, DB Buckley, PT Dytko, GM Murdock, PR Milligan, G Groarke, DA Tan, KB Shabon, U Nuthulaganti, P Wang, DY Wilson, S Bergsma, DJ Sarau, HM
Citation: Na. Elshourbagy et al., Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor, J BIOL CHEM, 275(34), 2000, pp. 25965-25971
A G protein-coupled receptor for UDP-glucose
Authors: Chambers, JK Macdonald, LE Sarau, HM Ames, RS Freeman, K Foley, JJ Zhu, Y McLaughlin, MM Murdock, P McMillan, L Trill, J Swift, A Aiyar, N Taylor, P Vawter, L Naheed, S Szekeres, P Hervieu, G Scott, C Watson, JM Murphy, AJ Duzic, E Klein, C Bergsma, DJ Wilson, S Livi, GP
Citation: Jk. Chambers et al., A G protein-coupled receptor for UDP-glucose, J BIOL CHEM, 275(15), 2000, pp. 10767-10771
Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey
Authors: Douglas, SA Sulpizio, AC Piercy, V Sarau, HM Ames, RS Aiyar, NV Ohlstein, EH Willette, RN
Citation: Sa. Douglas et al., Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey, BR J PHARM, 131(7), 2000, pp. 1262-1274
Identification of an EDG7 variant, HOFNH30, a G-protein-coupled receptor for lysophosphatidic acid
Authors: Fitzgerald, LR Dytko, GM Sarau, HM Mannan, IJ Ellis, C Lane, PA Tan, KB Murdock, PR Wilson, S Bergsma, DJ Ames, RS Foley, JJ Campbell, DA McMillan, L Evans, N Elshourbagy, NA Minehart, H Tsui, P
Citation: Lr. Fitzgerald et al., Identification of an EDG7 variant, HOFNH30, a G-protein-coupled receptor for lysophosphatidic acid, BIOC BIOP R, 273(3), 2000, pp. 805-810
In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity
Authors: Sarau, HM Foley, JJ Schmidt, DB Martin, LD Webb, EF Tzimas, MN Breton, JJ Chabot-Fletcher, M Underwood, DC Hay, DWP Kingsbury, WD Chambers, PA Pendrak, I Jakas, DR Sathe, GM Van Horn, S Daines, RA Griswold, DE
Citation: Hm. Sarau et al., In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity, PROS LEUK E, 61(1), 1999, pp. 55-64
Molecular cloning and expression of the rat monocyte chemotactic protein-3gene: a possible role in stroke
Authors: Wang, XK Li, X Yaish-Ohad, S Sarau, HM Barone, FC Feuerstein, GZ
Citation: Xk. Wang et al., Molecular cloning and expression of the rat monocyte chemotactic protein-3gene: a possible role in stroke, MOL BRAIN R, 71(2), 1999, pp. 304-312
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 (vol 401, pg 282, 1999)
Authors: Ames, RS Sarau, HM Chambers, JK Willette, RN Alyar, NV Romanic, AM Louden, CS Foley, JJ Sauermelch, CF Coatney, RW Ao, ZH Disa, J Holmes, SD Stadel, JM Martin, JD Liu, WS Glover, GI Wilson, S McNulty, DE Ellis, CE Elshourbagy, NA Shabon, U Trill, JJ Hay, DWP Ohlstein, EH Bergsma, DJ Douglas, SA
Citation: Rs. Ames et al., Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 (vol 401, pg 282, 1999), NATURE, 402(6764), 1999, pp. 898-898
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
Authors: Ames, RS Sarau, HM Chambers, JK Willette, RN Alyar, NV Romanic, AM Louden, CS Foley, JJ Sauermelch, CF Coatney, RW Ao, ZH Disa, J Holmes, SD Stadel, JM Martin, JD Liu, WS Glover, GI Wilson, S McNulty, DE Ellis, CE Elshourbagy, NA Shabon, U Trill, JJ Hay, DWP Ohlstein, EH Bergsma, DJ Douglas, SA
Citation: Rs. Ames et al., Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14, NATURE, 401(6750), 1999, pp. 282-286
Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1
Authors: Chambers, J Ames, RS Bergsma, D Muir, A Fitzgerald, LR Hervieu, G Dytko, GM Foley, JJ Martin, J Liu, WS Park, J Ellis, C Ganguly, S Konchar, S Cluderay, J Leslie, R Wilson, S Sarau, HM
Citation: J. Chambers et al., Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1, NATURE, 400(6741), 1999, pp. 261-265
Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor
Authors: Sarau, HM Ames, RS Chambers, J Ellis, C Elshourbagy, N Foley, JJ Schmidt, DB Muccitelli, RM Jenkins, O Murdock, PR Herrity, NC Halsey, W Sathe, G Muir, AI Nuthulaganti, P Dytko, GM Buckley, PT Wilson, S Bergsma, DJ Hay, DWP
Citation: Hm. Sarau et al., Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor, MOLEC PHARM, 56(3), 1999, pp. 657-663
Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412)
Authors: Giardina, GAM Raveglia, LF Grugni, M Sarau, HM Farina, C Medhurst, AD Graziani, D Schmidt, DB Rigolio, R Luttmann, M Cavagnera, S Foley, JJ Vecchietti, V Hay, DWP
Citation: Gam. Giardina et al., Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412), J MED CHEM, 42(6), 1999, pp. 1053-1065
Risultati: 1-25 | 26-28